Literature DB >> 17459442

Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F.

Yiliang Yang1, Fei Guo, Shan Cen, Lawrence Kleiman.   

Abstract

Vif-negative HIV-1 produced in non-permissive human cells incorporate both APOBEC3F (hA3F) AND APOBEC3G (hA3G), and have a severely reduced ability to produce viral DNA in newly infected cells. While it has been proposed that this reduction is due to deamination of deoxycytidine in viral DNA by either hA3G or hA3F, followed by DNA degradation, recent evidence indicates that the inhibition of viral DNA production can occur independently of DNA editing by either hA3F or hA3G. We have reported that the presence of hA3G in Vif-negative HIV-1 produced from either the non-permissive cell line, H9, or from transfected 293T cells transiently or stably expressing hA3G, results in a >or=50% reduction in the ability of primer tRNA(Lys3) to initiate reverse transcription in these virions, and that this is correlated with a similar reduction in the production of early DNA transcripts in the infected cells. In this work, we show that, like hA3G, hA3F in Vif-negative virions also results in a similar reduction in the initiation of reverse transcription in HIV-1, which is correlated with the inhibition of early viral DNA synthesis in the cell, and which does not require cytidine-deamination of DNA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459442     DOI: 10.1016/j.virol.2007.03.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  51 in total

1.  The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.

Authors:  Xiaoxia Wang; Zhujun Ao; Liyu Chen; Gary Kobinger; Jinyu Peng; Xiaojian Yao
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 2.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

3.  N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.

Authors:  Yudi Wang; Qiujia Shao; Xianghui Yu; Wei Kong; James E K Hildreth; Bindong Liu
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  Comparison of the replication and persistence of simian-human immunodeficiency viruses expressing Vif proteins with mutation of the SLQYLA or HCCH domains in macaques.

Authors:  Kimberly Schmitt; M Sarah Hill; Zhenqian Liu; Autumn Ruiz; Nathan Culley; David M Pinson; Edward B Stephens
Journal:  Virology       Date:  2010-09-01       Impact factor: 3.616

5.  Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

Authors:  John S Albin; William L Brown; Reuben S Harris
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

6.  Cellular HIV-1 inhibition by truncated old world primate APOBEC3A proteins lacking a complete deaminase domain.

Authors:  Miki Katuwal; Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Kalani Halemano; Mario L Santiago; Edward B Stephens
Journal:  Virology       Date:  2014-09-28       Impact factor: 3.616

7.  Hypermutation of an ancient human retrovirus by APOBEC3G.

Authors:  Young Nam Lee; Michael H Malim; Paul D Bieniasz
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.

Authors:  Andrew E Armitage; Aris Katzourakis; Tulio de Oliveira; John J Welch; Robert Belshaw; Kate N Bishop; Beatrice Kramer; Andrew J McMichael; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

Review 9.  Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

Authors:  Jessica L Smith; Wei Bu; Ryan C Burdick; Vinay K Pathak
Journal:  Trends Pharmacol Sci       Date:  2009-12       Impact factor: 14.819

10.  A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.

Authors:  Anjie Zhen; Tao Wang; Ke Zhao; Yong Xiong; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.